Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
Pulmonary Arterial Hypertension PAH
Wuhan, Hubei
Pulmonary Arterial Hypertension PAH Clinical Trials in Wuhan, Hubei
1 recruiting
Wuhan, Hubei, China
Showing
1–1
of
1
trials
Recruiting
Phase 1
Phase 2
A Phase Ⅰb/Ⅱa Clinical Study of IMC-003 Injection for the Treatment of Pulmonary Arterial Hypertension Receiving Background Therapy.
Pulmonary Arterial Hypertension PAH
ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd.
120 enrolled
32 locations
NCT07593027
Feedback